Today's Top Odd News Story

Giant rabbit dies after United Airlines flight to United States

LONDON (Reuters) - A 3-foot-long giant rabbit died at a United Airlines pet holding facility in Chicago following a flight from London, in another embarrassment for the airline as it struggles with a global backlash this month over a passenger dragged from his seat. Learn More

 

More Top Odd Stories

Conservatives back latest U.S. healthcare bill, obstacles remain

WASHINGTON (Reuters) - The conservative House Freedom Caucus came out in support of a reworked U.S. healthcare overhaul bill even though it would not fully repeal Democratic former President Barack Obama's signature healthcare law, the group said in a statement on Wednesday. More »

 

Swiss drugmaker Roche confident sales growth will overcome generic threat

ZURICH (Reuters) - Swiss drugmaker Roche, encouraged by better than expected first-quarter sales, said it was confident new drugs will help to deliver revenue and profit growth even as its older medicines take a hit from cheaper copies. More »

 

Synairgen loses half its value as AstraZeneca dumps drug

LONDON (Reuters) - British biotech firm Synairgen lost nearly half its value on Thursday as partner AstraZeneca pulled the plug on an experimental drug designed to help patients fight common cold viruses. More »

 

Drugmaker AbbVie's profit, revenue beat as Humira sales rise

(Reuters) - AbbVie Inc's quarterly profit and revenue beat analysts' estimates, helped by demand for its top-selling treatment, Humira. More »

 

Bristol-Myers beats Wall St estimates, helped by Cancer drug Opdivo

NEW YORK (Reuters) - Bristol-Myers Squibb Co on Thursday posted better-than-expected first-quarter earnings, helped by growth from cancer drugs Opdivo and Yervoy and blood thinner Eliquis. More »

 

Celgene quarterly sales misses on soft demand for psoriasis drug

(Reuters) - U.S. biotechnology company Celgene Corp reported lower-than-expected sales, hurt in part by soft demand for its psoriasis treatment even as sales of its flagship drug Revlimid beat estimates. More »

 

Merck cholesterol drug Vytorin faces competition from Impax, Teva generics

(Reuters) - Merck & Co's cholesterol-reducing drug Vytorin faces competition for the first time ever after two companies announced progress on their generic versions of a drug that generated more than $1 billion in sales last year. More »

 

Pregnancy complications await childhood cancer survivors

(Reuters Health) - Women who manage to conceive after surviving childhood cancer may encounter treatment-related pregnancy and labor complications if they got radiation for their malignancies, a recent study suggests. More »

 

White House to keep paying Obamacare subsidies for now: official

WASHINGTON (Reuters) - The Trump administration will continue to pay subsidies for low-income Americans receiving healthcare coverage under Obamacare, but no decisions have been made about future funding, a White House official said on Wednesday. More »

 

News, Photo and Web Search